A detailed history of Investment Research Partners LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Investment Research Partners LLC holds 12,955 shares of BMY stock, worth $606,423. This represents 0.25% of its overall portfolio holdings.

Number of Shares
12,955
Holding current value
$606,423
% of portfolio
0.25%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Dec 01, 2025

BUY
$43.31 - $48.98 $561,081 - $634,535
12,955 New
12,955 $552 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Investment Research Partners LLC Portfolio

Follow Investment Research Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Research Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Investment Research Partners LLC with notifications on news.